why is Pharma leaving the money on the floor and not mass producing this?
Both the other comments here are on-point. The materials for large amounts of radvac would cost pennies per dose, because the cost-per-unit of the peptides drops very rapidly as you scale up (remember, we doubled our order for <10% extra cost).
However, in general, people and logistics are a bigger expense than materials for most products these days, and I certainly expect that to apply to vaccines.
Both the other comments here are on-point. The materials for large amounts of radvac would cost pennies per dose, because the cost-per-unit of the peptides drops very rapidly as you scale up (remember, we doubled our order for <10% extra cost).
However, in general, people and logistics are a bigger expense than materials for most products these days, and I certainly expect that to apply to vaccines.